Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Crofton EJ"'
Autor:
Crofton EJ; Departments of Psychiatry.; Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.; Bowles Center for Alcohol Studies, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.; Department of Psychology and Neuroscience, Emmanuel College, Boston, Massachusetts 02115., O'Buckley TK; Bowles Center for Alcohol Studies, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599., Bohnsack JP; Departments of Psychiatry.; Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.; Bowles Center for Alcohol Studies, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599., Morrow AL; Departments of Psychiatry.; Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.; Bowles Center for Alcohol Studies, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599., Herman MA; Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 melissa_herman@unc.edu.; Bowles Center for Alcohol Studies, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.
Publikováno v:
The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2023 Oct 18; Vol. 43 (42), pp. 7056-7068. Date of Electronic Publication: 2023 Sep 01.
Autor:
Crofton EJ; Bowles Center for Alcohol Studies, The University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, USA; Department of Psychiatry, The University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, USA; Department of Pharmacology, The University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, USA; Department of Psychology and Neuroscience, Emmanuel College, Boston, MA, USA., Zhu M; Bowles Center for Alcohol Studies, The University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, USA; Department of Pharmacology, The University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, USA; Neuroscience Curriculum, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Curtis KN; Department of Psychology and Neuroscience, Emmanuel College, Boston, MA, USA., Nolan GW; Department of Psychology and Neuroscience, Emmanuel College, Boston, MA, USA., O'Buckley TK; Bowles Center for Alcohol Studies, The University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, USA., Morrow AL; Bowles Center for Alcohol Studies, The University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, USA; Department of Psychiatry, The University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, USA; Department of Pharmacology, The University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, USA., Herman MA; Bowles Center for Alcohol Studies, The University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, USA; Department of Pharmacology, The University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, USA. Electronic address: melissa_herman@unc.edu.
Publikováno v:
Neuropharmacology [Neuropharmacology] 2022 Mar 01; Vol. 205, pp. 108912. Date of Electronic Publication: 2021 Dec 06.
Autor:
Crofton EJ; Dept. of Pharmacology and Toxicology, Center for Addiction Research, Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, TX, 77555, USA; Neuroscience Graduate Program University of Texas Medical Branch, Galveston, TX, 77555, USA., Nenov MN; Dept. of Pharmacology and Toxicology, Center for Addiction Research, Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, TX, 77555, USA., Zhang Y; Dept. of Pharmacology and Toxicology, Center for Addiction Research, Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, TX, 77555, USA; Pharmacology and Toxicology Graduate Program University of Texas Medical Branch, Galveston, TX, 77555, USA., Tapia CM; Dept. of Pharmacology and Toxicology, Center for Addiction Research, Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, TX, 77555, USA; Pharmacology and Toxicology Graduate Program University of Texas Medical Branch, Galveston, TX, 77555, USA., Donnelly J; Dept. of Pharmacology and Toxicology, Center for Addiction Research, Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, TX, 77555, USA., Koshy S; Dept. of Pharmacology and Toxicology, Center for Addiction Research, Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, TX, 77555, USA., Laezza F; Dept. of Pharmacology and Toxicology, Center for Addiction Research, Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, TX, 77555, USA., Green TA; Dept. of Pharmacology and Toxicology, Center for Addiction Research, Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, TX, 77555, USA. Electronic address: thgreen@utmb.edu.
Publikováno v:
Neuropharmacology [Neuropharmacology] 2021 Feb 01; Vol. 183, pp. 108398. Date of Electronic Publication: 2020 Nov 09.
Autor:
Agoglia AE; Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, 27599, USA; Department of Pharmacology, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, 27599, USA., Crofton EJ; Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, 27599, USA; Department of Pharmacology, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, 27599, USA; Department of Psychiatry, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, 27599, USA., Herman MA; Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, 27599, USA; Department of Pharmacology, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, 27599, USA. Electronic address: melher@email.unc.edu.
Publikováno v:
Neuropharmacology [Neuropharmacology] 2020 Jun 15; Vol. 170, pp. 108045. Date of Electronic Publication: 2020 Mar 07.
Autor:
Hughes BA; Department of Psychiatry, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, 27599, NC, USA; Department of Pharmacology, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, 27599, NC, USA; Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, 27599, NC, USA., Crofton EJ; Department of Psychiatry, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, 27599, NC, USA; Department of Pharmacology, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, 27599, NC, USA; Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, 27599, NC, USA., O'Buckley TK; Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, 27599, NC, USA., Herman MA; Department of Pharmacology, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, 27599, NC, USA; Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, 27599, NC, USA., Morrow AL; Department of Psychiatry, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, 27599, NC, USA; Department of Pharmacology, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, 27599, NC, USA; Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, 27599, NC, USA. Electronic address: leslie_morrow@med.unc.edu.
Publikováno v:
Neuropharmacology [Neuropharmacology] 2020 Jan 01; Vol. 162, pp. 107805. Date of Electronic Publication: 2019 Oct 04.
Autor:
Zhang Y; Mental Health Research Group, Center for Addiction Research, Mitchell Center for Neurodegenerative Diseases, Dept. of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA., Crofton EJ; Mental Health Research Group, Center for Addiction Research, Mitchell Center for Neurodegenerative Diseases, Dept. of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA., Smith TES; Mental Health Research Group, Center for Addiction Research, Mitchell Center for Neurodegenerative Diseases, Dept. of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA., Koshy S; Mental Health Research Group, Center for Addiction Research, Mitchell Center for Neurodegenerative Diseases, Dept. of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA., Li D; Mental Health Research Group, Center for Addiction Research, Mitchell Center for Neurodegenerative Diseases, Dept. of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA., Green TA; Mental Health Research Group, Center for Addiction Research, Mitchell Center for Neurodegenerative Diseases, Dept. of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA. Electronic address: thgreen@utmb.edu.
Publikováno v:
Behavioural brain research [Behav Brain Res] 2019 Dec 30; Vol. 376, pp. 112177. Date of Electronic Publication: 2019 Aug 23.
Autor:
Scala F; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77550, USA; Biophysics Graduate Program, Institute of Human Physiology, Università Cattolica, Rome, Italy., Nenov MN; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77550, USA., Crofton EJ; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77550, USA; Neuroscience Graduate Program, The University of Texas Medical Branch, Galveston, TX 77550, USA., Singh AK; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77550, USA., Folorunso O; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77550, USA., Zhang Y; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77550, USA; Pharmacology and Toxicology Graduate Program, The University of Texas Medical Branch, Galveston, TX 77550, USA., Chesson BC; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77550, USA; Pharmacology and Toxicology Graduate Program, The University of Texas Medical Branch, Galveston, TX 77550, USA., Wildburger NC; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77550, USA., James TF; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77550, USA; Neuroscience Graduate Program, The University of Texas Medical Branch, Galveston, TX 77550, USA., Alshammari MA; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77550, USA; Pharmacology and Toxicology Graduate Program, The University of Texas Medical Branch, Galveston, TX 77550, USA; Studies Abroad Program, King Saud University, Riyadh, Saudi Arabia., Alshammari TK; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77550, USA; Pharmacology and Toxicology Graduate Program, The University of Texas Medical Branch, Galveston, TX 77550, USA; Studies Abroad Program, King Saud University, Riyadh, Saudi Arabia., Elfrink H; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77550, USA; Bench Tutorials Program: Scientific Research and Design, The University of Texas Medical Branch, Galveston, TX 77550, USA., Grassi C; Institute of Human Physiology, Università Cattolica, Rome, Italy; Fondazione Policlinico Universitario A. Gemelli, Rome, Italy., Kasper JM; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77550, USA; Center for Addiction Research, The University of Texas Medical Branch, Galveston, TX 77550, USA., Smith AE; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77550, USA; Center for Addiction Research, The University of Texas Medical Branch, Galveston, TX 77550, USA; Cell Biology Graduate Program, The University of Texas Medical Branch, Galveston, TX 77550, USA., Hommel JD; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77550, USA; Center for Addiction Research, The University of Texas Medical Branch, Galveston, TX 77550, USA., Lichti CF; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77550, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, Galveston, TX 77550, USA., Rudra JS; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77550, USA., D'Ascenzo M; Institute of Human Physiology, Università Cattolica, Rome, Italy., Green TA; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77550, USA; Center for Addiction Research, The University of Texas Medical Branch, Galveston, TX 77550, USA., Laezza F; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77550, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, Galveston, TX 77550, USA; Center for Addiction Research, The University of Texas Medical Branch, Galveston, TX 77550, USA. Electronic address: felaezza@utmb.edu.
Publikováno v:
Cell reports [Cell Rep] 2018 Apr 10; Vol. 23 (2), pp. 555-567.
Autor:
Crofton EJ; Center for Addiction Research, The University of Texas Medical Branch, Galveston, TX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, Galveston, TX, USA; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA., Nenov MN; Center for Addiction Research, The University of Texas Medical Branch, Galveston, TX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, Galveston, TX, USA; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA., Zhang Y; Center for Addiction Research, The University of Texas Medical Branch, Galveston, TX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, Galveston, TX, USA; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA., Scala F; Center for Addiction Research, The University of Texas Medical Branch, Galveston, TX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, Galveston, TX, USA; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA; Biophysics Graduate Program, Institute of Human Physiology, Universita Cattolica, Rome, Italy., Page SA; Center for Addiction Research, The University of Texas Medical Branch, Galveston, TX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, Galveston, TX, USA; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA., McCue DL; Center for Addiction Research, The University of Texas Medical Branch, Galveston, TX, USA; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA., Li D; Center for Addiction Research, The University of Texas Medical Branch, Galveston, TX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, Galveston, TX, USA; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA., Hommel JD; Center for Addiction Research, The University of Texas Medical Branch, Galveston, TX, USA; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA., Laezza F; Center for Addiction Research, The University of Texas Medical Branch, Galveston, TX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, Galveston, TX, USA; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA., Green TA; Center for Addiction Research, The University of Texas Medical Branch, Galveston, TX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, Galveston, TX, USA; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA. Electronic address: tom.green@utmb.edu.
Publikováno v:
Neuropharmacology [Neuropharmacology] 2017 May 01; Vol. 117, pp. 49-60. Date of Electronic Publication: 2017 Jan 23.
Autor:
Zhang Y; Center for Addiction Research, The University of Texas Medical Branch, Galveston, TX, USA; Dept. of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, Galveston, TX, USA., Crofton EJ; Center for Addiction Research, The University of Texas Medical Branch, Galveston, TX, USA; Dept. of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, Galveston, TX, USA., Fan X; Center for Addiction Research, The University of Texas Medical Branch, Galveston, TX, USA; Dept. of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, Galveston, TX, USA., Li D; Center for Addiction Research, The University of Texas Medical Branch, Galveston, TX, USA; Dept. of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, Galveston, TX, USA., Kong F; Dept. of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX, USA., Sinha M; Sealy Center for Molecular Medicine, Institute for Translational Science, The University of Texas Medical Branch, Galveston, TX, USA., Luxon BA; Dept. of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX, USA; Sealy Center for Molecular Medicine, Institute for Translational Science, The University of Texas Medical Branch, Galveston, TX, USA., Spratt HM; Dept. of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX, USA; Sealy Center for Molecular Medicine, Institute for Translational Science, The University of Texas Medical Branch, Galveston, TX, USA; Dept. of Preventative Medicine and Community Health, The University of Texas Medical Branch, Galveston, TX, USA., Lichti CF; Dept. of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, Galveston, TX, USA., Green TA; Center for Addiction Research, The University of Texas Medical Branch, Galveston, TX, USA; Dept. of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, Galveston, TX, USA. Electronic address: tom.green@utmb.edu.
Publikováno v:
Neuroscience [Neuroscience] 2016 Dec 17; Vol. 339, pp. 254-266. Date of Electronic Publication: 2016 Oct 04.
Transcriptomics of Environmental Enrichment Reveals a Role for Retinoic Acid Signaling in Addiction.
Autor:
Zhang Y; Center for Addiction Research, The University of Texas Medical Branch, GalvestonTX, USA; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, GalvestonTX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, GalvestonTX, USA., Kong F; Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, GalvestonTX, USA; Biomedical Informatics Program, The University of Texas Medical Branch, GalvestonTX, USA., Crofton EJ; Center for Addiction Research, The University of Texas Medical Branch, GalvestonTX, USA; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, GalvestonTX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, GalvestonTX, USA., Dragosljvich SN; Center for Addiction Research, The University of Texas Medical Branch, GalvestonTX, USA; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, GalvestonTX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, GalvestonTX, USA., Sinha M; Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, GalvestonTX, USA; Biomedical Informatics Program, The University of Texas Medical Branch, GalvestonTX, USA; Sealy Center for Molecular Medicine, Institute for Translational Science, The University of Texas Medical Branch, GalvestonTX, USA., Li D; Center for Addiction Research, The University of Texas Medical Branch, GalvestonTX, USA; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, GalvestonTX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, GalvestonTX, USA., Fan X; Center for Addiction Research, The University of Texas Medical Branch, GalvestonTX, USA; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, GalvestonTX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, GalvestonTX, USA., Koshy S; Center for Addiction Research, The University of Texas Medical Branch, GalvestonTX, USA; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, GalvestonTX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, GalvestonTX, USA., Hommel JD; Center for Addiction Research, The University of Texas Medical Branch, GalvestonTX, USA; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, GalvestonTX, USA., Spratt HM; Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, GalvestonTX, USA; Biomedical Informatics Program, The University of Texas Medical Branch, GalvestonTX, USA; Sealy Center for Molecular Medicine, Institute for Translational Science, The University of Texas Medical Branch, GalvestonTX, USA; Department of Preventive Medicine and Community Health, The University of Texas Medical Branch, GalvestonTX, USA., Luxon BA; Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, GalvestonTX, USA; Biomedical Informatics Program, The University of Texas Medical Branch, GalvestonTX, USA; Sealy Center for Molecular Medicine, Institute for Translational Science, The University of Texas Medical Branch, GalvestonTX, USA., Green TA; Center for Addiction Research, The University of Texas Medical Branch, GalvestonTX, USA; Department of Pharmacology and Toxicology, The University of Texas Medical Branch, GalvestonTX, USA; Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, GalvestonTX, USA.
Publikováno v:
Frontiers in molecular neuroscience [Front Mol Neurosci] 2016 Nov 16; Vol. 9, pp. 119. Date of Electronic Publication: 2016 Nov 16 (Print Publication: 2016).